Sunday, 17 February 2019

GSK plans to appoint new Chairman

22 January 2019 | News

Sir Philip Hampton has informed the Board of his intention to step down as non-executive Chairman.

image credit- bbc.com

image credit- bbc.com

GlaxoSmithKline plc (GSK), a science-led global healthcare company, has announced that Sir Philip Hampton has informed the Board of his intention to step down as non-executive Chairman and the Board has started the process to find a successor.

Sir Philip was appointed to the Board on 1st January 2015. He was appointed as Deputy Chairman from 1st April 2015 and as Chairman from 7th May 2015.

Vindi Banga, GSK’s Senior Independent Director, said: “The Group has a clear strategy, is delivering improved operating performance and has a clear pathway forward, this is a good time to start the process to find Philip’s successor.”

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account